This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

REGULATORY

Drug Discovery Support Project for Academia to Receive 3-Fold Budget Increase in FY2015

The Ministry of Health, Labor and Welfare (MHLW) will receive the full 3.4 billion yen it asked for in its budget request for FY2015 for its “drug discovery support project,” ... > Read full story
REGULATORY
PM Abe Promises to Introduce Patient-Initiated Mixed-Care System while Maintaining Universal Healthcare (Jan.30)
ORGANIZATION
IMI, WADA Sign MOU to Prevent Use of Experimental Drugs for Doping (Jan.30)
REGULATORY
Drug Wholesalers Should Stress Annual Price Cuts “Infeasible”: Ex-Minister (Jan.30)
REGULATORY
MHLW Warns of Severe Febrile Neutropenia for Cabazitaxel (Jan.30)
BUSINESS
Chugai to Set Up Global Organization to Bolster Early Clinical Development Functions (Jan.30)
> More Latest News

Photosmore

  
Drug Wholesalers Should Stress Annual Price Cuts “Infeasible”: Ex-Minister (Jan.30)Expenditure for Senshin-Iryo Services Totaled 17.4 Billion Yen: MHLW (Jan.29)PD-1, PD-L1 Inhibitors Could Carve Out 750 Billion Yen Market in Japan: Citi Analyst (Jan.28)
  
Panel on Unapproved Drugs Weighs Revamp upon Rollout of New Development Request Scheme (Jan.27)Cost of Producing Antibody Drugs Remains High Despite Improvement in Culture Efficiency: Kyowa Kirin (Jan.27)Nihon Chouzai Confident of Continuing Early Price Settlements (Jan.23)

News Categories

REGULATORY
   PM Abe Promises to Introduce Patient-Initiated Mixed-Care System while Maintaining Universal Healthcare(Jan.30)
   Drug Wholesalers Should Stress Annual Price Cuts “Infeasible”: Ex-Minister(Jan.30)
   MHLW Warns of Severe Febrile Neutropenia for Cabazitaxel(Jan.30)
BUSINESS
   Chugai to Set Up Global Organization to Bolster Early Clinical Development Functions(Jan.30)
   Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear(Jan.30)
   Abilify Rakes in US Sales of Nearly US$5 Billion in 2014: Otsuka(Jan.29)
ORGANIZATION
   IMI, WADA Sign MOU to Prevent Use of Experimental Drugs for Doping(Jan.30)
   July-Sept. Generic Share Reaches 51.3% under New Formula: JGA(Jan.30)
   JPMA Draft Guidelines Urge Companies to Separate Ad Reviewing Bodies from Sales Units(Jan.27)
ACADEMIA
   Yamagata Univ. Hospital Introduces Anticancer Agent Dispensing Robot(Jan.23)
   Nagoya University Concludes Diovan Study Data Trustworthy(Dec.24)
   AGs Could Hinder Optimization of Healthcare Spending, Reduce Patients’ Options: Prof. Sakamaki(Dec.24)

Commentary

Open Innovation Bandwagon Gathers Pace for Efficient Drug Discovery

Lexicon

Conditional, Time-Limited Approval:
条件・期限付き承認

The Column

Eliminating Bias from the Interview Process

Archives

July-Sept. Generic Share Reaches 51.3% under New Formula: JGA(Jan.30)
Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear(Jan.30)
Abilify Rakes in US Sales of Nearly US$5 Billion in 2014: Otsuka(Jan.29)
Chuikyo’s HTA Panel Holds First Closed-Door Meeting(Jan.29)
Chugai Sales Grow 8.8% Thanks to Increasing Actemra Exports(Jan.29)

Most Read

1.
Japan-Version C...
2.
Editor’s Pick: ...
3.
Chuikyo Members...
4.
Council OKs App...
5.
PMDA Evaluating...

News Calendar